This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, Germany

Anne Tolstrup
CEO at AbtBioConsult ApS


Anne B. Tolstrup, Ph.D., is an experienced biopharmaceutical industry professional with more than 25 years of involvement in the areas of biologics cell line and process development, genetics analyses, scale-up, process validation including process performance qualification (PPQ), clinical and commercial GMP manufacturing. She has extensive experience working in biotech and biopharma companies including Symphogen, Boehringer Ingelheim and Biogen as well as substantial experience with regulatory agencies, including FDA and EMA, regarding IND and BLA filings and audits. After starting her own consultancy business, AbtBioConsult in 2018 Anne has supported more than 35 clients in various aspects of biologics drug development including strategic support, CDMO collaborations, regulatory filings, and technical due diligence.

Agenda Sessions

  • Chairperson Remarks

  • Will technological progress in CLD enable a faster track to the patient?